Editorial: Should frailty be treated with testosterone?

Aging Male

Volumn 14, Issue 1, 2011, Pages 1-3

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; HEMOGLOBIN; PRASTERONE; TESTOSTERONE; ANDROGEN;

ANEMIA; BODY MOVEMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISABILITY; EDITORIAL; EXHAUSTION; FATIGUE; FUNCTIONAL STATUS; GRIP STRENGTH; HEART FAILURE; HIP FRACTURE; HUMAN; HYPOGONADISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN SYNTHESIS; RISK FACTOR; SATELLITE CELL; STRENGTH; VITAMIN D DEFICIENCY; WALKING DIFFICULTY; WEIGHT REDUCTION; AGED; AGING; DRUG EFFECT; FRAIL ELDERLY; MALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

AGED; AGED, 80 AND OVER; AGING; ANDROGENS; FRAIL ELDERLY; HUMANS; MALE; QUALITY OF LIFE; TESTOSTERONE;

EID: 79751520385     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2010.502271     Document Type: Editorial

References (46)

1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Bark G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-M156. (Pubitemid 32187141)
2. Rockwood K, Abeysundera MJ, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc 2007;8:595-603. (Pubitemid 350056388)
3. Abellan van Kan G, Rolland YM,Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc 2008;9: 71-72. (Pubitemid 351189169)
4. Abellan van Kan G, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B. The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008;12:29-37. (Pubitemid 351156012)
5. Morley JE, Kim MJ, Haren MT, Kevorkian R, Banks WA. Frailty and the aging male. Aging Male 2005;8:135-140. (Pubitemid 43068301)
6. Morley JE, Perry HM III, Miller DK. Editorial: something about frailty. J Gerontol A Biol Sci Med Sci 2002;57: M698-M704.
7. Syddall H, Roberts HC, Evandrou M, ooper C, Bergman H, Aihie Sayer A. Prevalence and correlates of frailty among community-dwelling older men and women: findings from the Hertfordshire Cohort Study. Age Aging 2010;39:197-203.
8. Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009;15:3384-3395.
9. Chu LW, Tam S, Lee PW, Wong RL, Yik PY, Tsui W, Song Y, Cheung BM,Morley JE, Lam KS. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf) 2008;68: 589-598. (Pubitemid 351388715)
10. Flood JF, Farr SA, Kaiser FE, LaRegina M, Morley JE. Agerelated decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav 1995;57:669-673.
11. Kohn FM. Testosterone and body functions. Aging Male 2006;9:183-188. (Pubitemid 46009604)
12. Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008;9:545-551.
13. Rolland Y, Czerwinski S, Abellan van Kan G, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boire Y, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008;12:433-450.
14. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal practice status. J Gerontol A Biol Sci Med Sci 2003;58:618-625. (Pubitemid 36900168)
15. Bhasin S. Testosterone supplementation for aging-associated sarcopenia. J Gerontol A Biol Sci Med Sci 2003;58: 1002-1008. (Pubitemid 37467297)
16. Valenti G, Denti L, MaggioM, Ceda G, Volpato S, Bandinelli S, Ceresini G, Cappola A, Guralnik JM, Ferrucci L. Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004;59:466-472. (Pubitemid 38649938)
17. MaggioM, Basaria S, Ceda GP, Ble A, Ling SM, Bandinelli S, Valenti G, Ferrucci L. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 2005;28(11 Suppl):116-119.
18. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Ling SM, Metter EJ, Artoni A, Carassale L, Cazzato A, Ceresini G, et al. Relationship between low levels of anabolic hormones and 6- year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med 2007;167:2249-2254. (Pubitemid 350106746)
19. Stenholm S, Maggio M, Lauretani F, Bandinelli S, Ceda GP, Di Loria A, Diallaurie F, Guralnik JM, Ferrucci L. Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANTI study. Rejuvenation Res 2010;13: 3-11.
20. Morley JE. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des 2007;13:3637-3647. (Pubitemid 350238934)
21. Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull, in press DOI: 10.1093/bmb/Idq008.
22. Kim MJ, Rolland Y, Cepeda O, Gammack JK, Morley JE. Diabetes mellitus in older men. Aging Male 2006;9:139-147. (Pubitemid 44529632)
23. Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenicobesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'Osteoporose) Study. Am J Clin Nutr 2009;89:1895-1900.
24. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004;12:1995-2004.
25. Bales CW, Buhr G. Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life. J Am Med Dir Assoc 2008;9:302-312. (Pubitemid 351737314)
26. Morley JE. Vitamin D redux. J Am Med Dir Assoc 2009;10: 591-592.
27. Braddy KK, Imam SN, Palla KR, Lee TA. Vitamin D deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis. J Am Med Dir Assoc 2009;10:653-657.
28. Hamid Z, Riggs A, Spencer T, Redman C, Bodenner D. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc 2007;8:71-75. (Pubitemid 46196421)
29. Perry HM III, Horowitz M, Morley JE, Patrick P, Vellas B, Baumgartner R, Garry PJ. Longitudinal changes in serum 25- hydroxyvitamin D in older people. Metabolism 1999;48: 1028-1032. (Pubitemid 29374922)
30. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-2264. (Pubitemid 40629192)
31. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. Br Med J 2009;339:b3692.
32. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-1737. (Pubitemid 47403059)
33. Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, Lau E, Lane NE, Stefanick ML, et al. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 2009;94:3806-3815.
34. Mohr BA, Bhasin S, Kupelian V, Araujo AB, O'Donnell AB, McKinlay JB. Testosterone, sex hormone-binding globulin, an frailty in older men. J Am Geriatr Soc 2007;55:548-555. (Pubitemid 46496587)
35. Travison TG, Shackleton R, AraujoA,Morley JE, Williams RE, Clark RV, McKinlay JB. Frailty, serum androgens and theCAG repeat polymorphism: Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab, 2010;95:2746-2754.
36. Morley JE, Perry HM III, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM III. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993;41:149-152. (Pubitemid 23051423)
37. Sih R,Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12- month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661-1667. (Pubitemid 127495166)
38. Page ST, Amory JK, Bowman FD, Anawatt BD, Matsumoto AM, Brenner WJ, Tenover JL. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005;90:1502-1510. (Pubitemid 40464011)
39. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA, Wu FC. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639-650.
40. Jankowska EA, Biel B, Majda J, Szklarska A, Lopaszanskol M, Medras M, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006;114:1829-1837. (Pubitemid 44673358)
41. Guder G, Frantz S, Bauersachs J, Frantz S, Bauersachs J, Allolio B, Ertl G, Angermann CE, Stork S. Low circulating androgens and mortality risk in heart failure. Heart 2010;96: 504-509.
42. Caminiti G, Volterrani M, Iellamo F, Marrazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009;54:919-927.
43. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer KS. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 2006;27:57-64. (Pubitemid 41785933)
44. Chapman IM, Visvanathan R, Hammond AJ, Morley JE, Field JB, Tai K, Belobrajdic DP, Chen RY, Horowitz M. Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr 2009;89:880-889.
45. Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypodonadism in males. Aging Male 2009;12:5-12.
46. Lunenfeld B, Nieschlag E. Testosterone therapy in the aging male. Aging Male 2007;10:139-153. (Pubitemid 47265837)